subscribeSubscribe
price-trendAsk Us
Stem cell transplants may slow disability progression in MS

Stem cell transplants may slow disability progression in MS
Caroline Peachey EUROPEANPHARMACEUTICALREVIEW
22 Dec 2022
Share Share
Belimumab Plus Standard Lupus Nephritis Therapy Improves Renal Responses

Belimumab Plus Standard Lupus Nephritis Therapy Improves Renal Responses
RENAL & NEURO NEWS
09 Jun 2021
Share Share
Alkem`s Generic Dabigatran Etexilate Mesylate Tentative Receives Approval in US

Alkem`s Generic Dabigatran Etexilate Mesylate Tentative Receives Approval in US
FDA
31 Mar 2020
Share Share
Sandoz completes acquisition of Aspen’s Japanese operations, strengthening

Sandoz completes acquisition of Aspen’s Japanese operations, strengthening
PRESS RELEASE
03 Feb 2020
Share Share
FDA Grants Fast Track Designation to the Baricitinib for SLE

FDA Grants Fast Track Designation to the Baricitinib for SLE
PR NEWSWIRE
22 Dec 2018
Share Share
FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Rare Vasculitis

FDA Approves Label Update for Genentech’s Rituxan (Rituximab) in Rare Vasculitis
BUSINESSWIRE
20 Oct 2018
Share Share
Fermion`s new plant operational in Hanko - nearly 100% of production is exported

Fermion`s new plant operational in Hanko - nearly 100% of production is exported
PRESS RELEASE
14 Jun 2018
Share Share
FDA Approves OLUMIANT® for Moderately-to-Severe Active Rheumatoid Arthritis

FDA Approves OLUMIANT® for Moderately-to-Severe Active Rheumatoid Arthritis
PR NEWSWIRE
01 Jun 2018
Share Share
Rituxan Scores in Rare Vasculitis

Rituxan Scores in Rare Vasculitis
Nancy Walsh MEDPAGE TODAY
06 Apr 2015
Share Share
NICE Backs Three Ulcerative Colitis Treatments

NICE Backs Three Ulcerative Colitis Treatments
EXTERNAL LINK PMLiVE
20 Dec 2014
Share Share